Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

NCT06287177 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-01-22

No results posted yet for this study

Summary

Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population

Conditions

Interventions

DRUG

Inclisiran

Injection

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-02-29
Completion
2030-11-01
FDA Drug
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06287177 on ClinicalTrials.gov